Texas Oncology is closed in observance of the upcoming holiday. View More Important Notifications x
texas oncology more breakthroughs. more victories
  • Request an Appointment
  • Find a cancer center
  • Find a provider
  • Clinical Trials

Share:

 
 

Physician Publications

Date
Physicians
Publication
Title
Berenson J, Manges R, Badarinath S, Cartmell A, McIntyre K, Lyons R, Harb W, Mohamed H, Nourbakhsh A, Rifkin R.
American Journal of Hematology 
A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 hour, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma
Roger M. Lyons, M.D., FACP
Leukemia Research
Relation Between Chelation and Clinical Outcomes in Lower-Risk Patients with Myelodysplastic Syndromes
Mittendorf E.A., Ardavanis A., Symanowski J., Murray J.L., Shumway N.M., Litton J.K., Hale D.F., Perez S.A., Anastasopoulou E.A., Pistamaltzian N.F., Ponniah S., Baxevanis C.N., von Hofe E., Papamichail M., Peoples G.E.
Annals of Oncology
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.
Jackson, D and Perez, S and Hale, D and Greene, J and Schneble, E and Martin, J and Flores, M and Berry, J and Trappey, A and Vreeland, TJ, Hardin MO, Clifton GT, Herbert GS, Shumway, N, Papamichail M, Mittendorf EA, Peoples GE
Annals of Surgical Oncology
Correlation Between Preexisting Immunity and Clinical Response in a Phase II Trial Using HER2-Based Peptide Vaccines to Prevent Breast Cancer Recurrence
Vreeland TJ, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Hardin MO, Clifton GT, Herbert GS, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA.
Annals of Surgical Oncology
Efficacy of Booster Inoculations in a Phase II Trial of GP2, a HER2-Derived Peptide Vaccine, for the Prevention of Breast Cancer Recurrence
Hardin MO, Jackson DO, Hale DF, Greene JM, Schneble EJ, Martin J, Flores M, Berry JS, Trappey AF, Vreeland TJ, Clifton GT, Herbert GS, von Hofe E, Perez S, Shumway N, Papamichail M, Peoples GE, Mittendorf EA. 
Annals of Surgical Oncology
Impact of Boosting in the Phase II Trial of the AE37+ GM-CSF Vaccine in High-risk Breast Cancer Patients to Prevent Recurrence
Giuliani M, Hope A, Mangona VS, Guckenberger M, Mantel F, Peulen H, Sonke J, Belderbos J, Werner-Wasik M, Ye H, Grills IS.
Clinical Lung Cancer
Predictors and Patterns of Regional Recurrence Following Lung SBRT: A Report From the Elekta Lung Research Group.
Johnson MD, Sura K, Mangona VS, Glick A, Ye H, Grills IS
Clinical Lung Cancer
Matched Pair Analysis of High Dose versus Standard Dose Definitive Chemoradiation for Locally Advanced Non-small Cell Lung Cancer.
Wilks, Sharon T. & Schnadig, Ian
Future Oncology
APF530 (Granisetron Inj Extended-Release) in a Three-Drug Regimen for Delayed CINV in Highly Emetogenic Chemotherapy
Agiro A, Ma Q, Acheson AK, Wu SJ, Patt DA, Baron JJ, Malin J, Schilsky RL, Lyman GH
Journal of Clinical Oncology
Risk of Neutropenia-Related Hospitalization in Patients Who Received Colony-Stimulating Factors with Chemotherapy for Breast Cancer
Hirsch BR, Burke JM, Agrawal M, Hauke RJ, Hutson TE, Doshi G, et al.
Journal of Kidney Cancer and VHL
Sequential therapy in metastatic renal cell carcinoma.
Patt D
Journal of Oncology Practice
Better Screening Using Big Data
Chiu L., Chow R., Popovic M., Navari R.M., Shumway N.M., Chiu N., Lam H., Milakovic M., Pasetka M., Vuong S., Chow E., DeAngelis C.
Support Care Cancer
Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.
Isis Gayed, MD, Robert Amato,MD, Gurjyot Doshi, MD, Mina Fanous,MD, David Wan,MD, Usha Joseph, MD, Steven Canfield, MD.
2015 World Molecular Imaging Congress. Hawaii
“Early experience with Radium 223 Xofigo Therapy in Patients with Prostate Bony Metastases” Poster Presentation
Zhu XR, Li Y, Mackin D, Li H, Poenisch F, Lee AK, Mahajan A, Frank SJ, Gillin MT, Sahoo N, Zhang X
Cancers
Towards effective and efficient patient-specific quality assurance for spot-scanning proton therapy
Mangona VS, Aneese AM, Hymas RV, Marina 0, lonascu D, Gallardo LJ, Yan D, Robertson JM, Grills IS
International Journal of Radiation Oncology, Biology and Physics
Toxicity After Central versus Peripheral Stereotactic Lung Radiotherapy (SBRT): A Propensity Score Matched-Pair Analysis.
V.S. Mangona, D.R. Grosshans, M. Chintagumpala, S. Khatua, N.V. Philip, M.F. McAleer, S.L. McGovern, J. Su, M.F. Okcu, A.C. Paulino, A. Mahajan
International Journal of Radiation Oncology, Biology and Physics
A. Clinical Outcomes of Children with Medulloblastoma After Proton Radiotherapy.
Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD
Journal of Clinical Oncology
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

John F. Sandbach
Gayle Patel, Elizabeth King, Brent Evans, John Kidd, Lucy Langer, Krystal L. Brown, Richard Wenstrup, Jennifer Saam

2015 ASCO Annual Meeting
A Study of Triple-Negative Breast Cancer Patients Tested With a 25-Gene Panel of Hereditary Cancer Genes.
Wilks, Sharon T., Yardley, etal.
American Society of Clinical Oncology
Weekly nab-Paclitaxel plus Gemcitabine (Gem) or Carboplatin (Carbo) versus Gem/Carbo as First Line Treatment for Metastatic Triple Negative (mTNBC) in a Phase II/III Trial (TnAcity).
Wilks, Sharon T., Slamon, et al.
American Society of Clinical Oncology
Predictive Biomarkers of Everolimus efficacy in HER2+ Advanced Breast Cancer: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
Bersabe, Adrian REYES and Osswald, Michael B and Shumway, Nathan M
ASCO Annual Meeting Proceedings
Correlation of peripheral blood smear review and bone marrow biopsies for benign hematology Outpatient referrals.
Greene JM, Schneble EJ, Martin J, Flores M, Berry, Trappey AF, Vreeland TJ, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Shumway N, Ponniah S, Papamichail M, Perez S, Symanowski JT, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
Final pre-specified analysis of the phase II trial of the AE37+ GM-CSF vaccine in high risk breast cancer patients to prevent recurrence.
Liang C, Li L, Fraser CD, Ko A, Corzo D, Enger C, Patt D
BMC Cancer
The treatment patterns, efficacy, and safety of nab-paclitaxel for the treatment of metastatic breast cancer in the United States: results from health insurance claims analysis
Wilks, S. & McIntyre, K
Clinical Medicine Insights: Oncology
Case Studies in the Management of Metastatic Breast Cancer with Eribulin.
Andre, Fabrice, Sara Hurvitz, Angelica Fasolo, Ling-Ming Tseng, Guy Jerusalem, Sharon Wilks, Ruth O’Regan, Claudine Isaacs, Masakazu Toi, Howard Burris, Wei He, Douglas Robinson, Markus Riester Riester, Tetiana Taran, David Chen and Dennis Salmon
Journal of Clinical Oncology
Molecular Alterations and Everolimus  Efficacy in HER2-Overexpressing Metastatic Breast Cancers: Combined Exploratory Analysis from BOLERO-1 and BOLERO-3.
Shumway, Nathan M and Dacus, Jennifer J and Lathrop, Kate I and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
Journal of Graduate Medical Education
Use of milestones and development of entrustable professional activities in 2 hematology/oncology training programs
Shumway, Nathan M and Terrazzino, Sandra E and Jones, Christopher B
Journal of Pain Management
A randomized pilot study comparing olanzapine (Zyprexa) to aprepitant (Emend) for treatment of chemotherapy-induced nausea and vomiting
Denduluri N, Patt DA, Wang Y, Bhor M, Li X, Favret AM, Morrow PK, Barron RL, Asmar L, Saravanan S, Li Y, Garcia J, Lyman GH
Journal of the National Comprehensive Cancer Network
Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices
Stone BS, Mangona VS, Johnson MD, Ye Hong, Grills IS
Journal of Thoracic Oncology
Changes in Pulmonary Function Following Image Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline or Post-SBRT Pulmonary Function are Associated with Worse Overall Survival.
Yasenchak CA, Tseng WY, Yap M, Rembert D, Patt DA
Leukemia & Lymphoma
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
Wilks, S. et al
San Antonio Breast Cancer Symposium
Phase I study of GR antagonist Mifepristone (M) in combination with Eribulin (E)in advanced solid tumors, with dose expansion in patients (pts)with GR-positive Triple Negative Breast Cancer (TNBC).
Schnadig, Ian; Wilks, Sharon T.
San Antonio Breast Cancer Symposium
Phase 3 Comparison of APF530 versus Ondansetron, Each in a Guideline-Recommended 3-drug Regimen for Prevention of Chemotherapy Induced Nausea and Vomiting due to Anthracycline+ Cyclophosphamide (AC) Based Highly Emetogenic Chemotherapy (HEC) Regime.
O’Shaughnessy, J. et al., Wilks Sharon T.
Springer Plus Open Journal Volume 4
Impact of Prior Anthracycline or Taxane on Eribulin Effectiveness as First-Line Treatment for Metastatic Breast Cancer: Results from Two Phase 2, Multicenter, Single-arm Studies.
Wilks, Sharon T.
The Breast
Potential of Overcoming Resistance to HER2-Targeted Therapies through the PI3K/Akt/mTOR pathway.
Sturgeon JD, Crane CH, Krishnan S, Minsky BO, Skibber JM, Rodriguez-Bigas MA, Chang GJ, You YN, Eng C, Das P.
American Journal of Clinical Oncology
Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.
Shumway NM, Lathrop KI, Dacus JJ, Miller M, Hernandez EP, Karnad AB
Accreditation Council of Graduate Medical Education
Use Of Milestones And Development Of Entrustable Professional Activities (EPAs) In Hematology/Oncology (HO) Training Programs -- A Proactive And Practical Approach to a New Evaluation System.
Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE
American Journal of Clinical Oncology
The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer
Shumway, Nathan M and Dacus, Jennifer Jill and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Informed consent training for medical oncology fellows: Checklist-based simulation exercise.
Dacus, Jennifer Jill and Shumway, Nathan M and Lathrop, Kate Ida and Hernandez, Elizabeth P and Miller, Maria and Karnad, Anand B
ASCO Annual Meeting Proceedings
Chemotherapy infusion reaction training for medical oncology fellows: A checklist-based simulation exercise.
Mittendorf EA, Schneble EJ, Perez S, Symanowski JT, Patil R, Vreeland TJ, Berry JS, Trappey AF, Hale DF, Sears AK, Clifton GT, von Hofe E, Ardavannis A, Ponniah S, Shumway N, Papamichail M, Peoples GE. 
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, phase II trial of GP2+ GM-CSF vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients
Erika J Schneble, Sonia A. Perez, John S. Berry, Alfred F Trappey, Tim Vreeland, Diane F. Hale, Alan K. Sears, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Nathan M. Shumway, Sathibalan Ponniah, Michael Papamichail, George Earl Peoples, Elizabeth Ann Mittendorf
ASCO Annual Meeting Proceedings
Comparison of recurrent and nonrecurrent breast cancer patients undergoing AE37 peptide vaccine therapy.
Elizabeth Ann Mittendorf, Erika J Schneble, Sonia A. Perez, James T Symanowski, Ritesh Patil, Timothy J. Vreeland, John S. Berry, Alfred F Trappey, Guy T. Clifton, Eric von Hofe, Alexandros Ardavanis, Sathibalan Ponniah, Nathan M. Shumway, Michael Papamichail, George Earl Peoples
ASCO Annual Meeting Proceedings
Primary analysis of the prospective, randomized, single-blinded phase II trial of AE37 vaccine versus GM-CSF alone administered in the adjuvant setting to high-risk breast cancer patients.
Bersabe, Adrian R and Osswald, Michael and Shumway, Nathan M
Blood
Peripheral Blood Smear Utilization within a Military Hematology/Oncology Fellowship Program
Pugh TJ, Lee AK
Cancer Journal
Proton beam therapy for the treatment of prostate cancer
Wilks, Sharon et al
Clinical Breast Cancer
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.

Roger M. Lyons

International Blood Research & Reviews
Iron Overload, Chelation Therapy and Survival in Lower-risk Myelodysplastic Syndromes: State of Evidence

Download full publication here.

Sturgeon JD; Cox JA; Mayo LL; Gunn GB; Zhang J; Balter PA; Dong L; Awan M; Kocak-Uzel E; Mohamed AS; Rosenthal DI; Fuller CD.
International Journal of Computer Assisted Radiology and Surgery
Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy.
Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA
International Journal of Radiation Oncology
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial
Graham LJ, Shupe MP, Schneble EJ, Flynt FL, clemenshaw MN, Kirkpatrick AD, Gallagher C, Nissan A, Henry L, Stojadinovic A, Peoples GE, Shumway NM
Journal of Cancer
Current approaches and challenges in monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF. 
Journal of Cancer
Current approaches and challenges in early detection of breast cancer recurrence
Shupe, Matthew P and Graham, Lindsey J and Schneble, Erika J and Flynt, Frederick L and Clemenshaw, Michael N and Kirkpatrick, Aaron D and Stojadinovic, Alexander and Peoples, George E and Shumway, Nathan M
Journal of Cancer
Future directions for monitoring treatment responses in breast cancer
Schneble EJ, Graham LJ, Shupe MP, Flynt FL, Banks KP, Kirkpatrick AD, Nissan A, Henry L, Stojadinovic A, Shumway NM, Avital I, Peoples GE, Setlik RF.
Journal of Cancer
Future directions for the early detection of recurrent breast cancer
Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Gonzalez-Angulo AM, Kirshner JJ, Krop I, Levinson J, Modi S, Patt DA, Perez EA, Perlmutter J, Winer EP, Lin NU
Journal of Clinical Oncology
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Gonzalez-Angulo AM, Krop I, Levinson J, Lin NU, Modi S, Patt DA, Perez EA, Perlmutter J, Ramakrishna N, Winer EP
Journal of Clinical Oncology
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Patt DA
Journal of Community and Supportive Oncology
Taking on racial and ethnic disparities in cancer care
Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE
Journal of the National Comprehensive Cancer Network
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic
Mahmood U, Levy LB, Nguyen PL, Lee AK, Kuban DA, Hoffman KE
Journal of Urology
Current Clinical Presentation and Treatment of Localized Prostate Cancer in the United States

Roger M. Lyons
Billie J. Marek, Carole Paley, Jason Esposito, Lawrence Garbo, Nicholas DiBella, Guillermo Garcia-Manero

Leukemia Research
Comparison of 24-Month Outcomes in Chelated and non-Chelated Lower-risk Patients with Myelodysplastic Syndromes in a Prospective Registry

Download full publication here.

Zhuang L, Yan D, Liang J, lonascu D, Mangona V, Zhou J
Medical Physics
Evaluation of Image Guided Motion Management Methods in Lung Cancer Radiotherapy.
Wootton L, Kudchadker R, Lee A, Beddar S
Physics in Medicine and Biology
Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer
Zhu XR, Poenisch F, Li H, Zhang X, Sahoo N, Wu RY, Li X, Lee AK, Chang EL, Choi S, Pugh T, Frank SJ, Gillin MT, Mahajan A, Grosshans DR
Radiation Oncology
A single-field integrated boost treatment planning technique for spot scanning proton therapy

John Sandbach
Sami Diab, Patricia Rodriguez, Anna Leininger, Lisa Clarke, Mike F. Janicek, Ellen B. Smith, Jennifer Saam, Lucy Langer

San Antonio Breast Cancer Symposium
Experience in the Community Oncology Practice with a 25-Gene Hereditary Cancer Panel
Wilks, Sharon T., Andre, Fabrice, etal
The Lancet Oncology
Everolimus for Women with Trastuzumab Resistant, HER2 Positive, Advanced Breast Cancer (BOLERO-3): A Randomized, Double Blind, Placebo Controlled Phase III Trial.
Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A
Brachytherapy
Declining use of brachytherapy for the treatment of prostate cancer
Muren L, Rossi C, Hug E, Lee AK, Glimelius B
Acta Oncologica
Establishing and expanding the indications for proton and particle therapy
A Rojas-Martinez, AG Manzanera, SW Sukin, J Esteban-Maria, JF Gonzalez-Guerrero, L Gomez-Guerra, R Garza-Guajardo, JP Flores-Guterrez, G Elizondo Riojas, I Delgardo-Enciso, R Ortiz-Lopez, LK Aguilar, EB Butler, HA Barrera-Saldana, and E Aguilar-Cordova
Cancer Gene Therapy
Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer
Baschnagel A, Mangona V, Robertson J, Welsh R, Kestin L, Grills I
Clinical Oncology
Lung Metastases Treated with Image-guided Stereotactic Body Radiation Therapy.
Li X, Quan EM, Li Y, Pan X, Zhou Y, Wang X, Du W, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X
International Journal of Radiation Oncology
A Fully Automated Method for CT-on-Rails-Guided Online Adaptive Planning for Prostate Cancer Intensity Modulated Radiation Therapy
Park PC, Cheung JP, Zhu XR, Lee AK, Sahoo N, Tucker SL, Liu W, Li H, Mohan R, Court LE, Dong L
International Journal of Radiation Oncology
Statistical Assessment of Proton Treatment Plans under Setup and Range Uncertainties
Winey B, Shih B, Sahoo N, Lee A, Vapiwala N, Both S
International Journal of Radiation Oncology
Core Physics Competencies for Proton Therapy Training of Radiation Oncology and Medical Physics Residents and Fellows
Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK
International Journal of Radiation Oncology
Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer
Chen, C, Dhanda, R, Tseng, W, Forsyth, M, Patt, D
Journal of Oncology Practice
Evaluating Use Characteristics for the Oncotype DX 21-gene recurrence score and concordance with chemotherapy use in early stage breast cancer
Brow M, Hoverman JR, Patt D, Herman B, Verrilli D, Garey J, Beveridge R
Journal of the National Comprehensive Cancer Network
Defining cancer care quality or delivering quality cancer care?

Roger Lyons
Uwe Platzbecker, Raymond SM Wong, Amit Verma, Camille Abboud, Sergio Araujo, Tzeon-Jye Chiou, John Feigert, Su-Peng Yeh, Katharina Götze, Norbert-Claude Gorin, Peter Greenberg, Suman Kambhampati, Yoo-Jin Kim, Je-Hwan Lee, Marco Ruggeri, Valeria Santini, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey Chan, Michael Arning, Nicole Stone, Aristoteles Giagounidis

18th Congress of the European Hematology Association
Placebo-controlled, Randomized, Phase I/II Trial of the Thrombopoeitin Receptor Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia

Download full publication here.

John F. Sandbach, MD
Joyce O’Shaughnessy, MD; David Loesch, MD; Devchand Paul, DO, PhD; Christopher T. Stokoe, MD; John E Pippen, Jr., MD; Joanne L. Blum., MD, PhD; Lea K. Krekow, MD; Frankie Ann Holmes, MD; Svetislava J. Vukelja, MD; Deborah Lindquist, MD; Scot M. Sedlacek, MD; Yunfei Wang, PhD; Stephen Jones, MD.

 

2013 ASCO Annual Meeting
ER as a Predictor of Early Breast Cancer (EBC) Outcomes in Patients ≤ 40 Years.

Roger M. Lyons, MD
Gary E Raskob, PhD, Harry Buller, MD, PhD, Pantep Angchaisuksiri, MD, Doyeun Oh, MD, PhD, Zoltan Boda, MD, PhD, DSc, Jeffrey I. Weitz, MD, George Zhang, PhD, Hans J Lanz, MD, Michele Mercuri,
MD, PhD, FAHA

55th American Society of Hematology Annual Meeting and Exposition
Edoxaban for Long-Term Treatment of Venous Thromboembolism in Cancer Patients 

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. Dipersio, MD, PhD, John V. Catalano, MD, Michael W. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, Azra Raza, MD, Kris Vaddi, PhD, William Sun, PhD, Wei Peng, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

55th American Society of Hematology Annual Meeting and Exposition
Long-Term Outcomes of Ruxolitinib Therapy in Patients with Myelofibrosis: 3-Year Update From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Paul J. Shaughnessy, MD, Ann Kelley, RN, Roberta Tremper, RN, Jonathan Tinker, Carlos Bachier, MD, Joseph Holahan, MD, Charles F. LeMaistre, MD

55th American Society of Hematology Annual Meeting and Exposition
The VIP (Very Immunocompromised Patient ) Protocol: Improved Access to Care and Time to Antibiotics

Download full publication here.

Roger M. Lyons
Uwe Platzbecker, MD, PhD, Raymond S.M. Wong, Amit Verma, MD, Camille N. Abboud, MD, Sergio Araujo, Tzeon-Jye Chiou, MD, John Feigert, MD, Su-Peng Yeh, MD, Katharina Götze, M.D., Norbert Claude Gorin, MD, PhD, Peter L. Greenberg, MD, Suman Kambhampati, MD, Yoo Jin Kim, MD, Je-Hwan Lee, Marco Ruggeri, MD, Valeria Santini, MD, Gregory Cheng, Jun Ho Jang, Chien-Yuan Chen, Souria Hasan Dougherty, Frank Mannino, Yasser Mostafa Kamel, Geoffrey W. Chan, MD, Nicole L. Stone, PhD, Aristoteles Giagounidis, MD

55th American Society of Hematology Annual Meeting and Exposition
Randomized, Placebo-Controlled, Phase I/II Trial of the Thrombopoietin Receptor (TPO-R) Agonist Eltrombopag in Thrombocytopenic Patients with Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia—A Subgroup Analysis of Patients Receiving Concomitant Anticancer Therapy

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek, MD, Carole S. Paley, MD, Jason Esposito, MSHS, Katie McNamara, MSHS, CCRA, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

55th American Society of Hematology Annual Meeting and Exposition
48-Month Update on Survival and AML Transformation in a 600-Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Debra A. Patt, M.D. 
Clara Chen, M.S., Rahul Dhanda, Ph.D., Wan-Yu Tseng, M.S., Michael Forsyth, R.Ph., M.B.A

American Society of Clinical Oncology
Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer

Download full publication here.

Reeder-Hayes K, Felip E, Patt D, Jaffee E
American Society of Clinical Oncology
Women in oncology
Vreeland, TJ and Berry, JS and Trappey, AF and Hale, D and Clifton, GT and Sears, A and Shumway, NM and Holmes, JP and Ponniah, S and Mittendorf, EA and others
Annals Of Surgical Oncology
Use of an Attenuated Version of a Strongly Immunogenic, Peptide-based Vaccine to Enhance an Anti-cancer Immune Response against Folate Receptor-alpha (FR alpha)
Patil, Ritesh and Clifton, Guy T and Litton, Jennifer Keating and Shumway, Nathan M and Vreeland, Timothy J and Berry, John S and Trappey, Alfred F and Ponniah, Sathibalan and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and efficacy of the HER2-derived GP2 peptide vaccine in combination with trastuzumab for breast cancer patients in the adjuvant setting.
Trappey, Alfred F and Berry, John S and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Ponniah, Sathibalan and Perez, Sonia A and Clifton, Guy T and Papamichail, Michael and Shumway, Nathan M and others
ASCO Annual Meeting Proceedings
Risk factors for development of delayed urticarial reactions in the phase II trial of HER2 peptide vaccines plus GM-CSF versus GM-CSF alone in high-risk breast cancer patients to prevent recurrence.

Vivian Jean M. Cline-Burkhardt, M.D. 
J. Randolph Hecht, Allen Lee Cohn, Shaker R. Dakhil, Mansoor N. Saleh, Bilal Piperdi, Ying Tian, William Y. Go

ASCO University
SPIRITT (study 20060141): A randomized phase II study of FOLFIRI with either panitumumab (pmab) or bevacizumab (bev) as second-line treatment (tx) in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC).

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael Deininger, Carole Miller, Richard T. Silver, Moshe Talpaz,11 Elliott F. Winton, Jimmie H. Harvey Jr, Murat O. Arcasoy, Elizabeth Hexner, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, Hagop M. Kantarjian

British Journal of Haematology
The Clinical Benefit of Ruxolitinib Across Patient Subgroups: Analysis of a Placebo-controlled, Phase III Study in Patients with Myelofibrosis

Download full publication here.

Roger M Lyons
DJ Kuter, JB Bussel, A Newland, RI Baker, J Wasser, JF Viallard, G Macik, M Rummel, K Nie, S Jun.

British Journal of Haematology
Long-Term Treatment with Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP): Safety and Efficacy
Trappey, AF and Berry, JS and Vreeland, TJ and Guy, CT and Diane, HF and Alan, SK and Erika, SJ and Ferrise, L and Shumway, NM and Papamichail, M and others
Cancer Research
Abstract P4-13-05: HLA-A2 is not a prognostic indicator in breast cancer: Implications for cancer vaccine trials
Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Clifton, Guy T and Sears, Alan K and Shumway, Nathan M and Ponniah, Sathibalan and Holmes, Jarrod P and Ioannides, Constantin and others
Cancer Research
Use of an attenuated version of a strongly immunogenic, peptide-based vaccine to enhance an anti-cancer immune response against folate receptor-alpha.
Vreeland, TJ and John, BS and Trappey, AF and Schneble, EJ and Hale, DF and Clifton, GT and Shumway, NM and Perez, SA and Papamichail, M and Ponniah, S and others
Cancer Research
Breast cancer patients with HER2 low-expression: An under-recognized group at significant risk for recurrence
Berry, JS and Trappey, AF and Vreeland, TJ and Schneble, EJ and Clifton, GT and Hale, DF and Sears, AK and Ponniah, S and Shumway, NM and Mittendorf, EA and others
Cancer Research
Preliminary results for the phase 1 trial of a dual HER2 peptide cancer vaccine in breast and ovarian cancer patients

Roger M. Lyons
Deirdra R. Terrell, PhD, James N. George, MD, James B. Bussel, MD, MD, FACP, Vinod Pullarkat, MD, Robert L. Redner, MD, Dominik Selleslag, MD, Kun Nie, PhD, Paul Woodard, MD

Community Oncology
Self-Administration of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons
Andres Siulnik, Vikas Gupta, Mahmudul Khan, John F. DiPersio, Mari McQuitty, John V. Catalano, Deborah S. Hunter, Laurent Knoops, Michael Deininger, Francisco Cervantes, Carole Miller, Alessandro M. Vannucchi, Richard T. Silver, Tiziano Barbui, Moshe Talpaz, Giovanni Barosi, Elliott F. Winton, Estella Mendeson, Jimmie H. Harvey, Jr, Murat O. Arcasoy, Elizabeth Hexner, Richard Levy, Ronald Paquette, Azra Raza, William Sun, Victor Sandor, Hagop M. Kantarjian, Claire Harrison

Haematologica
Comparison of Placebo and Best Available Therapy for the Treatment of Myelofibrosis in the Phase 3 COMFORT Studies

Download full publication here.

Roger M. Lyons
Richard S. Levy, Srdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole B. Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie H. Harvey, Murat O. Arcasoy, Elizabeth O. Hexner, Roger M. Lyons, Ronald Paquette, Azra Raza, Kris Vaddi, Susan Erickson-Viitanen, William Sun, Victor Sandor, and Hagop M. Kantarjian

Haematologica
Efficacy, Safety and Survival with Ruxolitinib Treatment in Patients with Myelofibrosis: Results of a Median 2-year Follow-up of COMFORT-1

Download full publication here.

Schneble, Erika J and Berry, John S and Trappey, Alfred F and Vreeland, Timothy J and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Ponniah, Sathibalan and Shumway, Nathan M and Mittendorf, Elizabeth A and others
Journal for Immunotherapy of Cancer
Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients.

Roger M Lyons
Billie J. Marek, Carole S. Paley, Jason Esposito, Lawrence E. Garbo, Nicholas J. DiBella, Guillermo Garcia-Manero

Journal of Clinical Oncology
A 36-Month Analysis of Treatment Patterns of Outcomes in Patients with Lower-Risk Myelodysplastic Syndromes from a Prospective Observational Study

Download full publication here.

Roger M Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton11, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Count

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon I Hamburg, Josef T Prchal, Katarzyna Jamieson, Howard R Terebelo, Gregory L Ortega, Ramon V Tiu, Elliott F Winton, Kavita Natrajan, Olatoyosi Odenike, David Claxton, Wei Peng, Peter O’Neill, Susan Erickson-Viitanen, Lance Leopold, Victor Sandor, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

Journal of Hematology & Oncology
Interim Analysis of Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts

Download full publication here.

Pugh TJ, Amos RA, John Baptiste S, Choi S, Nhu Nguyen Q, Ronald Zhu X, Palmer MB, Lee AK
Medical Dosimetry
Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors
Pair ML, Du W, Rojas HD, Kanke JE, McGuire SE, Lee AK, Kuban DA, Kudchadker RJ
Medical Dosimetry
Dosimetric Effects of Weight Loss or Gain During Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiation Therapy for Prostate Cancer
Zhou J, Sebastian E, Mangona V, Yan D
Medical Physics
Real-time catheter tracking for high-dose-rate prostate brachytherapy using an electromagnetic 3D-guidance device: A preliminary performance study.
Li H, Sahoo N, Poenisch F, Suzuki K, Li Y, Li X, Zhang X, Lee AK, Gillin MT, Zhu XR
Medical Physics
Use of treatment log files in spot scanning proton therapy as part of patient-specific quality assurance
Ramsey SD, Sullivan SD, Reed SD, Tina Shih YC, Schaecher K, Dhanda R, Patt D, Pendergrass K, Walker M, Malin J, Schwartzberg L, Neumann K, Yu E, Ravelo A, Small A. 
Oncologist
Oncology comparative effectiveness research: a multistakeholder perspective on principles for conduct and reporting

Vivian J.M. Cline-Burkhardt 
Tyvin A Rich,Kathryn Winter,Howard Safran,John P. Hoffman,Beth Erickson,Pramila R. Anne,Robert J. Myerson,Kimberly Perez,Christopher Willett

OncoTargets and Therapy
Paclitaxel, gemcitabine, irradiation, and R115777 for pancreas cancer

Download full publication here.

Melancon AD, Lee AK, Kudchadker R, Zhang L, Tucker S, Kuban D, Dong L
Practical Radiation Oncology
Anatomic variation and dosimetric consequences of neoadjuvant hormone therapy before radiation therapy for prostate cancer
Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA
Prostate Cancer and Prostatic Diseases
Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients
Wilks, Sharon, et al.
San Antonio Breast Cancer Symposium
Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate + Trastuzumab as First Line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer.
Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE
Annals of Oncology
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer
Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW
Brachytherapy
Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy
Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA
European Journal of Cancer
Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?
McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA
International Journal of Radiation Oncology
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era
Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA
International Journal of Radiation Oncology 
Is Androgen Deprivation Therapy Necessary in All Intermediate-Risk Prostate Cancer Patients Treated in the Dose Escalation Era?

Joyce O’Shaughnessy, MD
Linda Vahdat, MD, Lee Schwartzberg, MD, Sharon Wilks, MD, FACP, Jessicca Rege, PhD, Wenquan Wang, PhD, David Cox, PhD

35th Annual San Antonio Breast Cancer Symposium
Eribulin Mesylate with Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2)-Positive Breast Cancer: Preliminary Results from a Phase 2, Multicenter, Single-Arm Study

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John V. Catalano, MD, Michael W.N. Deininger, MD, PhD, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth O. Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Susan Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian, MD

54th Annual Meeting of the American Society of Hematology
Long-Term Outcome of Ruxolitinib Treatment in Patients with Myelofibrosis: Durable Reductions in Spleen Volume, Improvements in Quality of Life, and Overall Survival Advantage in COMFORT-1

Download full publication here.

Roger M Lyons, MD
Billie J. Marek, MD, Carole Paley, MD, Jason Esposito, MSHS, Lawrence Garbo, MD, Nicholas DiBella, MD, Guillermo Garcia-Manero, MD

54th Annual Meeting of the American Society of Hematology
Relationship Between Chelation and Clinical Outcomes in 600 Lower-Risk MDS Patients: Registry Analysis At 36 Months

Download full publication here.

Roger M Lyons, MD
Sharon T. Wilks, MD, David J. Friedman, MD, PhD, Shelby A Young, RN, BSN, Gail Brown, MD

54th Annual Meeting of the American Society of Hematology
Oral Ezatiostat HCL (Telintra), a Glutathione Analog Prodrug GSTP-1Inhibitor, for Treatment of Patients with Myeloid Growth Factor-Resistant Idiopathic Chronic Neutropenia

Download full publication here.

Roger M. Lyons, MD
Douglas B. Cines, MD, Terry B. Gernsheimer, MD, Jeffrey Wasser, MD, Bertrand Godeau, MD, Andrew Provan, MD, Ivy Altomare, Xuena Wang, PhD, Paul Woodard, MD

54th Annual Meeting of the American Society of Hematology
Integrated Analysis of Long-Term Safety in Patients with Chronic Immune Thrombocytopenia Treated with Romiplostim

Download full publication here.

Roger M. Lyons
Moshe Talpaz, Ronald Paquette, Lawrence Afrin, Solomon Hamburg, Katarzyna Jamieson, Howard Terebelo, Gregory Ortega, Ramon V. Tiu, Elliott F. Winton, Kavita Natrajan, Olatoyosi Odenike, Wei Peng, Victor A. Sandor, Peter O'Neill, Sue Erickson-Viitanen, Lance Leopold, Richard S Levy, Hagop M Kantarjian, Srdan Verstovsek

54th Annual Meeting of the American Society of Hematology
Efficacy, Hematologic Effects, and Dose of Ruxolitinib in Myelofibrosis Patients with Low Starting Platelet Counts (50-100 x 10^9/L): A Comparison to Patients with Normal or High Starting Platelet Counts

Download full publication here.

Hale DF, Vreeland TJ, Dabney RS, Clifton GT, Sears AK, Pappou E, Anastosopoulou E, Ardavanis A, Ponniah S, Papamichail M, Perez S, Shumway N, Peoples GE, Mittendorf E.
American Association for Cancer Research AACR
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine

Roger M Lyons

American Journal of Medicine
Myelodysplastic Syndromes: Therapy and Outlook

Download full publication here.

Shumway, Nathan M and Struble, Erika J
ASCO Annual Meeting Proceedings
Prospective survey study regarding the implementation of new communication skills curriculum for medical oncology trainees.
Diane F Hale, Sonia A. Perez, Timothy J Vreeland, Alfred F Trappey, Raetasha Sheavette Dabney, John S. Berry, Alexandros Ardavanis, Alan K. Sears, Michael Papamichail, Guy T. Clifton, Efi Pappou, Ritesh Patil, Eleftheria Anastasopoulou, Sathibalan Ponniah, Nathan M. Shumway, George Earl Peoples and Elizabeth Ann Mittendorf 
ASCO Annual Meeting Proceedings
An assessment of disease features and immune response in breast cancer patients that did not recur after receiving HER2 peptide, AE37 vaccine in a randomized phase II trial.
Mittendorf, Elizabeth Ann and Perez, Sonia A and Hale, Diane F and Vreeland, Timothy J and Sears, Alan K and Clifton, Guy T and Ardavanis, Alexandros and Shumway, Nathan M and Murray, James L and Ponniah, Sathibalan and others
ASCO Annual Meeting Proceedings
Early efficacy analysis of the AE37 vaccine in patients with HER2 low-expressing and triple-negative breast cancer.
Dabney, Raetasha Sheavette and Hale, Diane F and Vreeland, Timothy J and Clifton, Guy T and Sears, Alan K and Patil, Ritesh and Ponniah, Sathibalan and Shumway, Nathan M and Peoples, George Earl and Mittendorf, Elizabeth Ann
ASCO Annual Meeting Proceedings
Safety and long-term maintenance of anti-HER2 immunity following booster inoculations of the E75 breast cancer vaccine.
Vreeland TJ, Hale DF, Sears AK, Clifton GT, Pappou E, Dabney RS, Ardavanis A, Patil R, Ponniah S, Anastasopoulou E, Perez SA, Papamichail M, Shumway NM, Peoples GE, Mittendorf EA.
ASCO Annual Meeting Proceedings
From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines.
Hale, DF and Vreeland, TJ and Perez, SA and Berry, JS and Ardavanis, A and Trappey, AF and Tzonis, P and Sears, AK and Clifton, GT and Shumway, NM and others
Cancer Research
The combination of trastuzumab and HER2-directed peptide vaccines is safe in HER2-expressing breast cancer patients
Vreeland, Timothy J and Dabney, Raetasha S and Hale, Diane F and Sears, Alan K and Clifton, Guy T and Zacharia, Athina and Jama, Yusuf and Chiplis, Anna and Mursal, Mohamed and Shumway, Nathan M and others
Cancer Research
Immune reconstitution after chemotherapy correlates with increased in vitro immune response in breast cancer patients undergoing peptide vaccine therapy
Diane F. Hale, Timothy J. Vreeland, Raetasha S. Dabney, G Travis Clifton, Alan K. Sears, Efi Pappou, Eleftheria Anastasopoulou, Alexandros Ardavanis, Sathibalan Ponniah, Michael Papamichail, Sonia Perez, Nathan Shumway, George E. Peoples, Elizabeth Mittendorf
Cancer Research
Abstract LB-218: Immune response assessment in a phase II trial of AE37 HER2 peptide vaccine
JM Greene, EJ Schneble, S Perez, JL Murray, JS Berry, AF Trappey, DF Hale, TJ Vreeland, GT Clifton, A Ardavanis, JK Litton, NM Shumway, M Papamichail, GE Peoples, EA Mittendorf 
Cancer Research
Abstract P2-11-01: Final pre-specified analysis of the phase II trial of the GP2+ GM-CSF peptide vaccine in high risk breast cancer patients to prevent recurrence

Weinthal, Joel, M.D

Clinical Roundtable Monograph
Disease State Awareness in Gaucher Disease: A Q&A Expert Roundtable Discussion
Brow M, Okon T, George E, Eagle D, Patt D, Gould B, Brooks B, Cobb P, White C, Tetrault S, Beveridge R.
Community Oncology
Thoughts and recommendations on cancer care site of service

John Sandbach, M.D. 
Lucy Langer, M.D., M.S.H.S., Lisa Clark, F.N.P., A.O.C.N.P., Justin Gress, Debra Patt, M.D., Neelima Denduluri, M.D., Yunfei Wang, Ph.D., Jay Andersen, M.D., Magdolna Solti, M.D., Amanda Wheeler, M.D., Tammy Delamelena, M.D., John Smith II, M.D.

Compass Oncology
A Structured Genetic Risk Evaluation and Testing Program in the Community Oncology Practice Increases Identification of Individuals at Risk for BRCA Mutations

Download full publication here.

R Lyons
S Verstovsek, R Mesa, J Gotlib, R Levy, V Gupta, J DiPersio, J Catalano, M Deininger, C Miller, R Silver, M Talpaz, E Winton, J Harvey, M Arcasoy, E Hexner, R Paquette, A Raza, K Vaddi, S Erickson-Viitanen, W Sun, V Sandor, H Kantarjian

European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes
Consistent Benefit of Ruxolitinib Over Placebo Across Myelofibrosis Patient Subgroups: Results From COMFORT-1

Download full publication here.

Doshi G, Sonpavde G, Sternberg CN.
Expert Opinion on Drug Metabolism & Toxicology
Clinical and pharmacokinetic evaluation of satraplatin.
Hale, Diane F and Clifton, G Travis and Sears, Alan K and Vreeland, Timothy J and Shumway, Nathan and Peoples, George E and Mittendorf, Elizabeth A
Expert Review of Vaccines
Cancer vaccines: should we be targeting patients with less aggressive disease?

John F. Sandbach, M.D. 
Anne-Renee Hartman, M.D., Rajesh R. Kaldate, M.S., Lisa M. Sailer, M.S.N., Lisa Painter, M.S.N., Charles E. Grier, Ph.D., Robbin R. Endsley, M.S., Marlena Griffin, B.S., Stephanie A. Hamilton, B.A., Cynthia A. Frye, M.S., Mark A. Silberman, M.D. and Richard J.Wenstrup, M.D.

Hartman
Prevalence of BRCA Mutations in an Unselected Population of Triple-Negative Breast Cancer

Download full publication here.

Quan EM, Li X, Li Y, Wang X, Kudchadker RJ, Johnson JL, Kuban DA, Lee AK, Zhang X
International Journal of Radiation Oncology
A Comprehensive Comparison of IMRT and VMAT Plan Quality for Prostate Cancer Treatment
Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Busby L, Brooks B, Sitarik M, Kolodiej M, Beveridge R
JCO supplements
Changes in adjuvant breast cancer chemotherapy regimen selection over time in the community
Wootton L, Kudchadker R, Beddar A, Lee AK
Journal of Applied Clinical Medical Physics
Effectiveness of a novel gas-release endorectal balloon in the removal of rectal gas for prostate proton radiation therapy

Roger M. Lyons
Moshe Talpaz, Solomon I. Hamburg, Katarzyna Jamieson, Howard R. Terebelo, Lawrence Afrin, Elliott F. Winton, Michael A. Scola, Jimmie Huling Harvey, Chris E. Holmes, Gregory L. Ortega, Josef T. Prchal, Richard T. Silver, Maria R. Baer, Susan Kay Erickson-Viitanen, Peter O'Neill, Wei Peng, Lance Leopold, Hagop Kantarjian, Srdan Verstovsek

Journal of Clinical Oncology
Preliminary Safety and Efficacy of Ruxolitinib in Patients with Primary and Secondary Myelofibrosis with Platelet Counts of 50-100x10^9L

Download full publication here.

Roger M. Lyons
Srdan Verstovsek, Ruben A. Mesa, Jason R. Gotlib, Vikas Gupta, John F. DiPersio, John V. Catalano, Michael W.N. Deininger, Carole Brennan Miller, Richard T. Silver, Moshe Talpaz, Elliott F. Winton, Jimmie Huling Harvey, Murat O. Arcasoy, Elizabeth O. Hexner,Ronald Paquette, Azra Raza, William Sun, Hagop Kantarjian

Journal of Clinical Oncology
Adverse Events and the Return of Myelofibrosis-Related Symptoms After Treatment Interruption or Discontinuation in the Comfort-I Study

Download full publication here.

Roger M. Lyons
Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen Matei, Bart Scott, Kuolung Hu, Allen S Yang

Journal of Hematology & Oncology
A Randomized, Double-blind, Placebo-controlled Phase 2 Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Azra Raza1, Naomi Galili1, Deborah Mulford, Scott E Smith, Gail L Brown, David P Steensma, Ralph Boccia, Mikkael A Sekeres, Guillermo Garcia-Manero, Ruben A Mesa

Journal of Hematology & Oncology
Phase 1 Dose-ranging Study of Ezatiostat Hydrochloride in Combination with Lenalidomide in Patients with Non-deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Berry, JS and Vreeland, TJ and Trappey, AF and Hale, DF and Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Holmes, JP and McCall, S and others
Journal of Immunotherapy
Trends in Circulating Tumor Cells (CTCS) in Multiple Adjuvant (ADJ) Trials of HER2-Specific Peptide Vaccines (PV) in Breast Cancer (BRCA) PTS
Archambault L, Poenisch F, Sahoo N, Robertson D, Lee A, Gillin MT, Mohan R, Beddar S
Medical Physics
Verification of proton range, position, and intensity in IMPT with a 3D liquid scintillator detector system
Cao W, Lim GJ, Lee A, Li Y, Liu W, Ronald Zhu X, Zhang X
Medical Physics
Uncertainty incorporated beam angle optimization for IMPT treatment planning

John Sandbach, M.D. 
Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Griffin M, Hamilton SA, Frye CA, Silberman MA, Wenstrup RJ.

Myriad Genetic Laboratories, Inc.
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer.

Roger M Lyons
Srdan Verstovsek, M.D., Ph.D., Ruben A. Mesa, M.D., Jason Gotlib, M.D., Richard S. Levy, M.D., Vikas Gupta, M.D., John F. DiPersio, M.D., Ph.D., John V. Catalano, M.D., Michael Deininger, M.D., Ph.D., Carole Miller, M.D., Richard T. Silver, M.D., Moshe Talpaz, M.D., Elliott F. Winton, M.D., Jimmie H. Harvey, Jr., M.D., Murat O. Arcasoy, M.D., Elizabeth Hexner, M.D., Ronald Paquette, M.D., Azra Raza, M.D., Kris Vaddi, Ph.D., Susan Erickson-Viitanen, Ph.D., Iphigenia L. Koumenis, M.S., William Sun, Ph.D., Victor Sandor, M.D., and Hagop M. Kantarjian, M.D.

New England Journal of Medicine
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

Download full publication here.

Rechner LA, Howell RM, Zhang R, Etzel C, Lee AK, Newhauser WD
Physics in Medicine and Biology
Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer
Pugh TJ, Choi S, Nguyen QN, Gillin M, Zhu R, Palmer M, Lee AK
Practical Radiation Oncology
Proton beam therapy for the treatment of prostate cancer
Sharp H, Swanson D, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno T, Kuban D, Lee AK, Choi S, Nguyen QN, Hoffman K, McGuire S, Frank S
Practical Radiation Oncology
Screening Colonoscopy Before Prostate Cancer Treatment Can Detect Colorectal Cancers in Asymptomatic Patients and Reduce the Rate of Complications After Brachytherapy
Klein D, Briere TM, Kudchadker R, Archambault L, Beaulieu L, Lee A, Beddar S
Radiation Measurements
In-phantom dose verification of prostate IMRT and VMAT deliveries using plastic scintillation detectors
Chawla, Vij et al.
Transplant Infectious Diseases
Oral Valganciclovir as Pre-emptive Therapy for CMV-Positive Patients After Allogeneic Hematopoietic Stem Cell Transplant: A Randomized Trial and Review of the Literature

Roger Lyons
Ruben Mesa, Jason Gotlib, Richard Levy, Vikas Gupta, John DiPersio, John Catalono, Michael Deininger, Carloe Miller, Richard Silver, Moshe Talpaz, Elliott Winton, Jimmie Harvey, Murat Arcasoy, Elizabeth Hexner, Roger Lyons, Ronald Paquette, Azra Raza, Kris, Vaddi, Sue Erikson-Viitanen, Iphegenia Koumenis, William Sun, Victor Sandor, Hagop Kantarjian

16th Congress of the European Hematology Association
Results of Comfort-1, A Randomized, Double-Blind Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib (INCB018424) Versus Placebo for Patients with Myelofibrosis

Download full publication here.

Haney B, Shumway NM, Peoples GE
Advances in the Management of Triple Negative Breast Cancer
Advances in the Management of Triple Negative Breast Cancer Ch.9: Targeted therapies: other agents in clinical trials
Sears, AK and Clifton, GT and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and Ponniah, S and Mittendorf, EA and Peoples, GE
ASCO Annual Meeting Proceedings
Sequential administration of trastuzumab and a CD8 T-cell-eliciting HER2/neu peptide vaccine in patients with breast cancer compared to trastuzumab alone.
Clifton, GT and Sears, AK and Patil, R and Shumway, NM and Carmichael, MG and Van Echo, DC and Holmes, JP and McCall, S and Merrill, GA and Ponniah, S and others
ASCO Annual Meeting Proceedings
Monitoring of circulating tumor cell trends in a prospective, randomized, placebo-controlled HER2/neu peptide vaccine trial.

Roger M. Lyons
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-1)

Download full publication here.

Roger M. Lyons
Azra Raza, MD, Naomi Galili, Ph.D., Deborah Mulford, MD, Scott E. Smith, MD, PhD, FACP, Gail Brown, MD, Lisa Meng, PhD, David P. Steensma, MD, Ralph Boccia, MD, Mikkael A. Sekeres, MD, MS, Guillermo Garcia-Manero, Ruben A. Mesa, MD

Blood
Phase I Dose-Ranging Study of Oral Ezatiostat Hydrochloride (Telintra, TLK199) in Combination with Lenalidomide (Revlimid) in Patients with Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Download full publication here.

Roger M. Lyons
Pierre Fenaux, MD, PhD, Hagop M. Kantarjian, Petra Muus, MD, PhD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Catherine Jia, PhD, Allen S. Yang, MD, PhD

Blood
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons, MD
Srdan Verstovsek, MD, PhD, Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Richard S. Levy, MD, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey Jr., MD, Murat O. Arcasoy, MD, Elizabeth Hexner, MD, Ronald Paquette, MD, PhD, Azra Raza, MD, Kris Vaddi, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Hagop M. Kantarjian

Blood
Consistent Benefit of Ruxolitinib Over Placebo in Spleen Volume Reduction and Symptom Improvement Across Subgroups and Overall Survival Advantage: Results From COMFORT-1

Download full publication here.

Roger M. Lyons, MD
Jeffrey Wasser, MD, Ralph Vincent V. Boccia, MD, Romeo Mandanas, Ingrid Pabinger, Marc Michel IV, Jean-François Viallard, MD-PhD, Xuena Wang, PhD, Richard Lizambri, MD

Blood
Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons, MD
Billie J. Marek1, Surabhi Sharma, Carole Paley, Jason Esposito, Lawrence Garbo, MD, NicholasnDiBella1, Guillermo Garcia-Manero

Blood
24-Month Analysis of the Impact of Chelation on Clinical Outcomes in 600 Patient Registry of Lower-Risk MDS Patients

Download full publication here.

Roger M. Lyons, MD
David J. Kuter, MD, DPhil, James B. Bussel, MD, Adrian Newland, FRCP, Jeffrey S. Wasser, MD, James N. George, MD, Gail Macik, MD, Kun Nie, Susie Jun

Blood
Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

Download full publication here.

Sears, Alan K and Perez, Sonia A and Clifton, Guy T and Benavides, Linda C and Gates, Jeremy D and Clive, Kevin S and Holmes, Jarrod P and Shumway, Nathan M and Van Echo, David C and Carmichael, Mark G and others
Expert Opinion on Biological Therapy
AE37: a novel T-cell-eliciting vaccine for breast cancer
Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A
International Journal of Radiation Oncology
Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? 
Zhu XR, Poenisch F, Song X, Johnson JL, Ciangaru G, Taylor MB, Lii M, Martin C, Arjomandy B, Lee AK, Choi S, Nguyen QN, Gillin MT, Sahoo N
International Journal of Radiation Oncology
Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose
Park PC, Zhu XR, Lee AK, Sahoo N, Melancon AD, Zhang L, Dong L
International Journal of Radiation Oncology
A Beam-specific Planning Target Volume (PTV) Design for Proton Therapy to Account for Setup and Range Uncertainties

Roger M Lyons
Craig Reynolds, Nicholas Di Bella, William Hyman, Donald A. Richards, Gerald J. Robbins, Mark Vellek, Kristi A. Boehm, Feng Zhan & Lina Asmar

Investigational New Drugs
A Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Busby L, Brooks, Kolodziej, Anderson R, Beveridge R
JCO Supplements
Utilization of pegfilgrastim in adjuvant chemotherapy regimens for breast cancer in the community
Chen C, Patt D, Kazzaz D, Shankleton J, Forsyth M, Ganesh R
JCO Supplements
Evaluating utilization characteristics for the Oncotype DX recurrence score in early-stage breast cancer
Ginsburg A, Patt D, Flinn J, Espirito J, Neubauer M, Cartwright T, Hoverman J, Busby B, Brooks, B Kolodziej M, Sitarik M, Anderson R, Beveridge R
JCO Supplements
Understanding male breast cancer in the community setting
Patt D, Espirito J, Turnwald B, Hoverman J, Neubauer M, Cartwright T, Brooks B, Busby L, Sitarik M, Kolodziej M, Ginsburg A, Sheth S, Garey J, Clayton M, Nelson R, Anderson R, Beveridge R
JCO Supplements
Utilization and relative value of breast cancer adjuvant chemotherapy regimens in the community
Heng L, Lee AK, Johnson J, Zhu R, Kudchadker R
Journal of Applied Clinical Medical Physics
Characterization of dose impact on IMRT and VMAT from couch attenuation for two Varian couches
Choi S, Lee AK
Journal of Drug, Healthcare and Patient Safety
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer

Roger M. Lyons
Sharon T Wilks, Shelby Young, Gail L Brown

Journal of Hematology & Oncology
Oral Ezatiostat HCl (Telintra, TLK199) and Idiopathic Chronic Neutropenia (ICN): A Case Report of Complete Response of a Patient with G-CSF Resistant ICN Following Treatment with Ezatiostat, a Glutathionie S-transferase P1-1 (GSTP1-1) Inhibitor

Download full publication here.

Kolodziej M, Hoverman JR, Garey JS, Espirito J, Sheth S, Ginsburg A, Neubauer MA, Patt D, Brooks B, White C, Sitarik M, Anderson R, Beveridge R
Journal of Oncology Practice
Benchmarks for value in cancer care: an analysis of a large commercial population
Hoverman, JR. Cartwright TH. Patt, DA. Espirito, JL. Clayton, MP. Garey, JS. Kopp, TJ. Kolodziej, M. Neubauer, M. Fitch, K. Pyenson, B. Beveridge, RA
Journal of Oncology Practice
Pathways, Outcomes, and Costs in Colon Cancer:  Retrospective evaluations in two distinct databases

Roger M Lyons
David Claxton, Harry P. Erba, Stefan Faderl, Martha Arellano, Tibor Kovacsovics, Janice Gabrilove, Dirk Huebner, Pritesh J. Gandhi, Hagop Kantarjian

Leukemia and Lymphoma
Outpatient Consolidation Treatment with Clofarabine in a Phase 2 Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia (AML)

Download full publication here.

R.M. Lyons
P. Fenaux, H. Kantarjian, R.A. Larson, M.A. Sekeres, P.S. Becker, P. Muus, C. Jia, A.S. Yang

Leukemia Research
Update of an Open-Label Extension Study Evaluating the Long-Term Safety & Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
G. Garcia-Manero, B.J. Marek, N. Martinez-Lopez, J. Esposito, C. Paley, N. DiBella

Leukemia Research
A 12-Month Follow-Up of an Ongoing Prospective, Non-Interventional, Multicenter Registry in Iron Overloaded Patients with Lower-Risk Myelodysplastic Syndromes

Download full publication here.

O’Shaughnessy, J. Osborne, C. Pippen, JE. Yoffee, M. Patt, D. Rocha C. Koo, IC. Sherman BM. Bradley, C.
New England Journal of Medicine
Iniparib plus Chemotherapy n Metastatic Triple-Negative Breast Cancer
Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen Q, Lee AK
Physica Medica
Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy
Pugh TJ, Lee AK
Urologic Clinics of North America
Role of radiation therapy for the treatment of lymph nodes in urologic malignancies
Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L
American Journal of Clinical Oncology
A volumetric trend analysis of the prostate and seminal vesicles during a course of intensity-modulated radiation therapy
Iyengar P, Levy LB, Choi S, Lee AK, Kuban DA
American Journal of Clinical Oncology
Toxicity Associated With Postoperative Radiation Therapy for Prostate Cancer

Roger M. Lyons
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran Jr, Philip Y. Dien, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, Lina Asmar

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or Refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Pierre Fenaux, MD, PhD, Hagop Kantarjian, MD, Richard A Larson, MD, Mikkael A Sekeres, MD, MS, Pamela Becker, MD, PhD, Petra Muus, MD, PhD, Catherine Jia, PhD,8 Allen S Yang, MD, PhD

 

Blood
Update from an Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes

Download full publication here.

Sandbach J
Eisenbraun A, Wenstrup R, Fry C, Reid, J, Hellerstedt, B, and Sailer, L

Community Oncology
Hereditary Breast and Ovarian Cancer Testing Integration and Outcomes within Community Oncology Practices.
Archambault L, Briere TM, Pönisch F, Beaulieu L, Kuban DA, Lee A, Beddar S
International Journal of Radiation Oncology
Toward a real-time in vivo dosimetry system using plastic scintillation detectors
Meyer J, Bluett J, Amos R, Levy L, Choi S, Nguyen QN, Zhu XR, Gillin M, Lee A
International Journal of Radiation Oncology
Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors
Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD
International Journal of Radiation Oncology
Late Rectal Toxicity on RTOG 94-06: Analysis Using a Mixture Lyman Model

Roger M. Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela S. Becker, Adam Boruchov, David Bowen, Eva Hellstrom-Lindberg, Richard A. Larson, Petra Muus, Jamile Shammo, Robert Siegel, Kuolung Hu, Janet Franklin, Dietmar P. Berger

Journal of Clinical Oncology
Safety and Efficacy of Romiplostim in Patient with Lower-risk Myelodysplastic Syndrome (MDS) and Thrombocytopenia

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Harry P. Erba, David Claxton, Martha Arellano, Tibor Kovascovics, Janice Gabrilove, Michael Craig, Dan Douer, Michael Maris, Stephen Petersdorf, Paul J. Shami, Andrew M. Yeager, Stephen Eckert, Rekha Abichandani, and Stefan Faderl

Journal of Clinical Oncology
Phase II Study of Clofarabine Monotherapy in Previously Untreated Older Adults with Acute Myeloid Leukemia and Unfavorable Prognostic Factors

Download full publication here.

Sandbach J
Loesch D, Greco FA, Senzer NN, Burris HA, Hainsworth JD, Jones S, Vukelja SJ, Holmes F, Sedlacek S, Pippen J, Lindquist D, McIntyre K, Blum JL, Modiano MR, Boehm KA, Zhan F, Asmar L, Robert N.

Journal of Clinical Oncology
Phase III Multicenter Trial of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel Compared With Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel As Adjuvant Therapy for Women With High-Risk Breast Cancer.
Neubauer, MA. Espirito, JL, Clayton, M. Patt, DA.
Journal of Clinical Oncology
Combination versus sequential chemotherapy for metastatic breast cancer: An evaluation of outcomes from a community oncology network
Grills IS, Mangona VS, Welsh R, Chmielewski G, Mcinerney E, Martin S, et al.
Journal of Clinical Oncology
Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer.

Barrera, David N. D.O. 
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran, Jr, Philip Y. Dien, Roger Lyons, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, and Lina Asmar 

Journal of the American Society of Hematology
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
Lee AK, Amling CL
Journal of the National Comprehensive Cancer Network
Appropriate use of nomograms to guide prostate cancer treatment selection
Socinski, MA. Raju, RN. Stinchombe, T. Kocs, DM. Couch, LS.Barrera, D. Rousey, SR. Choksi, JK. Jotte, R. Patt, DA. Periman, PO. Schlossberg, HR. Weissman, CH. Wang, Y. Asmar, L. Pritchard, S. Bromund J. Peng, G. Treat, J. Obasaju, CK.
Journal of Thoracic Oncology
Randomized phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer
Zhu XR, Sahoo N, Zhang X, Robertson D, Li H, Choi S, Lee AK, Gillin MT
Medical Physics
Intensity modulated proton therapy treatment planning using single-field optimization: the impact of monitor unit constraints on plan quality
Scholl, P. Snyder, N. Patt, D. Talbott, B
Otolaryngology-Head and Neck Surgery
Pilomatrical carcinosarcoma
Cheung J, Kudchadker RJ, Zhu XR, Lee AK, Newhauser WD
Physics in Medicine and Biology
Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer
Patt, D, Espirito, J, Turnwald, B, Hoang, S, Hoverman, J.
Proceedings ASCO Breast Cancer Symposium
Ixabepilone alone and in combination with chemotherapy in the community setting
Chawla & Ellis
Surgical Oncology Clinics of North America
A Review of Neoadjuvant Endocrine Therapy for Breast Cancer 
Shumway, NM and Terrazzino, SE and Jones, CB
ASCO Annual Meeting Proceedings
A randomized pilot study comparing aprepitant to olanzapine for treatment of chemotherapy-induced nausea and vomiting
Shumway, Nathan M and Ibrahim, Nuhad and Ponniah, Sathibalan and Peoples, George E and Murray, James L
BioDrugs
Therapeutic Breast Cancer Vaccines

Roger M. Lyons
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Roger M. Lyons, MD
Guillermo Garcia-Manero, Billie J. Marek, Noelia Martinez-Lopez, Carole Paley, Peter L. Greenberg

Blood
Clinical Parameters in 391 Iron-Overloaded Patients with Lower-Risk MDS Enrolled in a Prospective, Non-Interventional Multicenter Registry

Download full publication here.

Roger M. Lyons
Stefan Faderl, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Outpatient Treatment with Clofarabine in Phase II Study of Older Adult Patients with Previously Untreated Acute Myelogenous Leukemia

Download full publication here.

Roger M. Lyons
Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D, M. Arellano,  Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Elizabeth Anderson, Elly Barry, MD, Hagop M. Kantarjian, MD

Blood
Clorfarabine Produces Durable Remissions in Older Patients with AML with Unfavorable Prognostic Factors and Multiple Comorbidities

Download full publication here.

Roger M. Lyons
Harry P Erba, Stefan Fader, MD, David F. Claxton, MD, M. Arellano, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Single-Agent Clofarabine Produces Durable Remissions in Patients with Acute Myelogenous Leukemia (AML) Who > or = 70, Have Intermediate or Unfavorable Cytogenetics, Antecedent Hematological Disorders (AHD), or 2 or More Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Richard A. Larson, MD, Michael A. Kosmo, MD, Sunil Gandhi, Delong Liu, MD, PhD, Marc Chernoff, Luke Dreisbach, MD, Carmen Matei, Kuolong Hu, Ph, Janet L. Franklin, MD, MPH, Dietmar Berger, MD, PhD

Blood
Randomized Phase II Study Evaluating the Efficacy and Safety of Romiplostim Treatment of Patients with Low or Intermediate Risk Myelodysplastic Syndrome (MDS) Receiving Lenalidomide

Download full publication here.

Roger M Lyons
Janice Gabrilove, MD, Stefan Fader, MD, Harry P Erba, David F. Claxton, M.D., M. Arellano, Tibor J. Kovacsovics, MD, Stephen Eckert, Ph.D, Dirk Huebner, MD, Hagop M. Kantarjian, MD

Blood
Complete Response to Clofarabine Is Durable and Correlates with Survival in Previously Untreated Older Adults with Acute Myeloid Leukemia (AML) and Unfavorable Prognostic Factors

Download full publication here.

Roger M Lyons
Pierre Fenaux, Hagop Kantarjian, MD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Petra Muus, MD, PhD, Kuolong Hu, PhD, Dietmar Berger, MD, PhD, Janet L. Franklin, MD, MPH

Blood
An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M Lyons
Ralph V. Boccia, MD, Gail Macik, MD, Romeo A. Mandanas, MD, FACP, Xuena Wang, Richard Lizambri, MD,d Dietmar Berger, MD, PhD

Blood
Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP)

Download full publication here.

Roger M. Lyons
JN George, SD Mathias, RS Go RS, M Guo, DH Henry, RL Redner, L Rice, MR Schipperus

British Journal of Haematology
Improved Quality of Life for Romiplostim-Treated Patients with Chronic Immune Thormbocytopenic Purpura: Results from Two Randomized, Placebo-Controlled Trials

Roger M. Lyons, M.D., F.A.C.P.
Jamile M. Shammo, M.D., F.A.S.C.P., Lewis R. Silverman, M.D., Bart L. Scott, M.D.

Clinical Advances in Hematology & Oncology
Treatment Selection for Myelodysplastic Syndrome Patients in a Community Setting 

Download full publication here.

Fontenot JD, Lee AK, Newhauser WD
International Journal of Radiation Oncology
Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer
Kudchadker RJ, Lee AK, Yu ZH, Johnson JL, Zhang L, Zhang Y, Amos RA, Nakanishi H, Ochiai A, Dong L
International Journal of Radiation Oncology
Effectiveness of Using Fewer Implanted Fiducial Markers for Prostate Target Alignment

Roger M. Lyons
Thomas M. Cosgriff, Sanjiv S. Modi, Robert H. Gersh, John D. Hainsworth, Allen L. Cohn, Heidi J. McIntyre, Indra J. Fernando, Jay T. Backstrom, C.L. Beach

Journal of Clinical Oncology
Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R. M. Lyons
H. P. Erba, H. M. Kantarjian, D. F. Claxton, M. Arellano, T. J. Kovacsovics, J., Gabrilove, S. Eckert, S. Faderl

Journal of Clinical Oncology
Updated Remission Duration and Survival Results of Single-agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia Unlikely to Benefit From Standard Induction Chemotherapy Due to Unfavorable Baseline Risk Factor(s)

Download full publication here.

Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA
Journal of Urology
Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy
Smith A, Gillin M, Bues M, Zhu XR, Suzuki K, Mohan R, Woo S, Lee A, Komaki R, Cox J, Hiramoto K, Akiyama H, Ishida T, Sasaki T, Matsuda K
Medical Physics
The MD Anderson Proton Therapy System
Arjomandy B, Sahoo N, Cox J, Lee A, Gillin M
Physics in Medicine and Biology
Comparison of surface doses from spot scanning and passively scattered proton therapy beams
Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ
Urology
Urinary side effects and complications after permanent prostate brachytherapy: the MD Anderson Cancer Center experience
Chawla, Jane S.
Washington University in St. Louis
In Pursuit of Personalized Therapy for Breast Cancer: Gene Expression Signatures
Chawla, Jane S.
Washington University in St. Louis
A Phase II Study of Gemcitabine and a Multi-kinase Inhibitor in Metastatic Pancreatic Cancer
Chawla, Jane S.
Washington University in St. Louis
Neoadjuvant Chemotherapy for Rectal Cancer
Zhao, Sperry (Chawla), & Freeman et al.
Cancer Research
Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor B–Mediated Invasion and Metastasis in Pancreatic Cancer Cells 

Hoverman, J. Russell M.D. 
Radebaugh, K.A.

American Society Clinical Oncology
Imaging in Early Breast Cancer

McCollum, David M.D. 
Richards D, Wilfong L, Sborov M, Boehm KA, Zhan F, and Asmar L.

Annals of Oncology
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.

Roger M. Lyons, MD
Nicholas Di Bella, MD, Raymond Taetle, MD, Kathryn S. Kolibaba, MD, Thomas E Boyd, MD, Robert N Raju, MD, David N Barrera, DO, Ernest Cochran, MD, Philip Dien, MD, David Hakimian, MD, Peter J Schlegel, MD, Svetislava J Vukelja, MD, Julie Boston, RN, Kristi A Boehm, MS, Yunfei Wang, MS, Lina Asmar, PhD

Blood
Results of a Phase II Study of Bortezomib in Patients with Relapsed or refractory Indolent Lymphoma

Download full publication here.

Roger M. Lyons, MD
Craig Reynolds, MD, Nicholas Di Bella, MD, William J Hyman, MD, Gary L. Lee, MD, Donald A Richards, MD, PhD, Gerald J. Robbins, MD, Mark Vellek, MD, Kristi A Boehm, MS, Feng Zhan, PhD, Lina Asmar, PhD

Blood
Phase III Trial of Fludarabine, Cyclophosphamide, and Rituximab Vs. Pentostatin, Cyclophosphamide, and Rituximab in B-Cell Chronic Lymphocytic Leukemia

Download full publication here.

Roger M. Lyons, MD
Harry Paul Erba, MD, PhD, Hagop Kantarjian, David F. Claxton, MD, M. Arellano4, Tibor J. Kovacsovics, MD, Janice Gabrilove, MD, Stephen Eckert, Ph.D, Rekha Abichandani, MD, Stefan Faderl, MD

Blood
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous Leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Roger M. Lyons, MD
James George, MD, James B Bussel, MD, Vinod Pullarkat, MD, Robert Redner, MD, Deirdra Terrell, PhD, Kun Nie, PhD, Dietmar Berger, MD, PhD

Blood
Self-Injection of Romiplostim by Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons, MD
James B. Bussel, David J. Kuter, Vinod Pullarkat, Matthew Guo, Janet L. Nichol

Blood
Safety and Efficacy of Long-Term Treatment with Romiplostim in Thrombocytopenic Patients with ITP

Download full publication here.

Lim, S.H. M.D. 
Zhang, Y., Burris, C. and Townsend, M.

Bone Marrow Transplant

Successful salvage with unrelated umbilical cord blood transplant for Hodgkin’s disease relapsed following autologous stem cell transplant.

Esler, William Vance, M.D. 
Lim, S.H., Periman, P.O., Beggs, D., Zhang, Y., and Townsend, M.

British Journal of Haematology
R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Dianne Tomita, Lyndah Dreiling

British Journal of Haematology
Phase 2, Single-arm, Trial to Evaluate the Effectiveness of Darbopoetin alfa for Correcting Anaemia in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons, MD, FACP
Richard Stone, MD, Mikkael Sekeres, MD, MS, Guillermo Garcia-Manero, MD

Clinical Advances in Hematology & Oncology
Recent Advances in Low- and Intermediate-1--Risk Myelodysplastic Syndrome: Developing a Consensus for Optimal Therapy

Download full publication here.

Hutson, Thomas E. D.O., PharmD, FACP
MD Galsky.

Expert Review of Anticancer Therapy
Current optimal chemotherapy for advanced urothelial cancer.

R Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C.L. Beach

Haematologica
Rapid Onset of Effectiveness with Three Alternative Azacitidine (AZA) Dosing Regimens in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A
International Journal of Radiation Oncology
Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
O'Daniel JC, Dong L, Zhang L, Wang H, Tucker SL, Kudchadker RJ, Lee AK, Cheung R, Cox JD, Kuban DA, Mohan R
International Journal of Radiation Oncology
Daily bone alignment with limited repeat CT correction rivals daily ultrasound alignment for prostate radiotherapy
Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA
International Journal of Radiation Oncology
Quantification of prostate and seminal vesicle interfraction variation during IMRT
Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ
International Journal of Radiation Oncology
Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era?
Sejpal SV, Amos RA, Bluett JB, Levy LB, Kudchadker RJ, Johnson J, Choi S, Lee AK
International Journal of Radiation Oncology
Dosimetric Changes Resulting From Patient Rotational Setup Errors in Proton Therapy Prostate Plans

R. Lyons
H. P. Erba, H. M. Kantarjian, D. Claxton, M. Arellano, T. Kovacsovics, J. Gabrilove, S. Eckert, R. Abichandani, S. Faderl

Journal of Clinical Oncology
Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients with Acute Myelogenous leukemia (AML) Unlikely to Benefit from Standard Induction Chemotherapy

Download full publication here.

Jones, Stephen E. M.D. 
Luc Yves Dirix, Jorge Ignacio, Shona Nag, Poonamally Bapsy, Henry Gomez, Digumarti Raghunadharao, Robert Paridaens, Silvia Falcon, Marina Carpentieri, Antonello Abbattista, Jean-Pierre Lobelle

Journal of Clinical Oncology

Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination with Celecoxib

Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O, Prostate Specific Antigen Working Group
Journal of Urology
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time
Weiss, Brendan M and Shumway, Nathan M and Howard, Robin S and Ketchum, Lloyd K and Reid, Thomas J
Journal of Thrombosis and Thrombolysis
Optical density values correlate with the clinical probability of heparin induced thrombocytopenia

Roger M. Lyons
David J Kuter, James B Bussel, Vinod Pullarkat, Terry B Gernsheimer, Francis M Senecal, Louis M Aledort, James N George, Craig M Kessler, Miguel A Sanz, Howard A Liebman, Frank T Slovick, J Th M de Wolf, Emmanuelle Bourgeois, Troy H Guthrie Jr, Adrian Newland, Jeff rey S Wasser, Solomon I Hamburg, Carlos Grande, François Lefrère, Alan Eli Lichtin, Michael D Tarantino, Howard R Terebelo, Jean-François Viallard, Francis J Cuevas, Ronald S Go, David H Henry, Robert L Redner, Lawrence Rice, Martin R Schipperus, D Matthew Guo, Janet L Nichol

Lancet
Efficacy of Romiplostim in Patients with Chronic Immune Thrombocytopenic Purpura: a Double-blind Randomised Controlled Trial

Download full publication here.

Taddei PJ, Fontenot JD, Zheng Y, Mirkovic D, Lee AK, Titt U, Newhauser WD
Physics in Medicine and Biology
Reducing stray radiation dose to patients receiving passively scattered proton radiotherapy for prostate cancer

Esler, William Vance, M.D. 
Lim, S.H., Zhang, Y., Zhang, J., Periman, P.O., Burris, C., Townsend, M.

Leukemia and Lymphoma
B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
Sturgeon JD; Folsom AR; Longstreth WT; Shahar E; Rosamond WO; Cushman M.
Stroke
Hemostatic and Inflammatory Risk Factors for Intracerebral Hemorrhage in a Pooled Study.
Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL
Urologic Oncology
Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
Shumway, Nathan M and Wilson, Ramey L and Howard, Robin S and Parker, Joseph M and Eliasson, Arn H
Respiratory Medicine
Presence and treatment of air hunger in severely ill patients
Chawla, Jane S.
UT Southwestern
Paroxysmal Nocturnal Hemoglobinuria
Chawla, Jane S.
Washington University in St. Louis
The Natural Killer Cell Neoplasms: Can We Overcome Treatment Resistance?

John Sandbach, MD
David Loesch, MD; F. Anthony Greco, MD; Joyce O'Shaughnessy, MD; Nicholas Robert, MD; Neil N. Senzer, MD; John D. Hainsworth, MD; Sasha Vukelja, MD; Frankie Holmes, MD; Scot Sedlacek, MD; Deborah Lindquist, MD; Jario Olivares, MD; Kristi A. Boehm, MS; Feng Zhan, PhD; Lina Asmar, PhD

ASC Journal of Clinical Oncology
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer
Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL
BJU International
Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?
Lee AK, D'Amico AV
BJU International
Using prostate-specific antigen doubling time in clinical practice

R. Lyons
T. Cosgriff, S. Modi, H. McIntyre, I. Fernando, J. Backstrom, C. L. Beach

Blood
Results of the Initial Treatment Phase of a Study of Three Alternative Dosing Schedules of Azacitidine (Vidaza) in Patients with Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger Lyons
James N. George, Francois Lefrere, Alan E. Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean-Francois Viallard, Reggie Kelly, Matthew Guo, Janet Nichol

Blood
Evaluation of AMG 531 Safety in Splenectomized (S) and Nonsplenectomized (NS) Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in Two Randomized Placebo-Controlled Phase 3 Studies

Download full publication here.

Roger Lyons
James N. George, Francis J. Cuevas, Ronald S. Go, David H. Henry, Robert L. Redner, Lawrence Rice, Martin R. Schipperus, Susan D. Mathias, Sue Gao, Matthew Guo, Janet L. Nichol

Blood
Health-Related Quality of Life (HRQoL) in Patients with Chronic Immune Thrombocytopenic Purpura (ITP): Results from Two Placebo-Controlled Phase 3 Studies of AMG 531

Download full publication here.

Roger Lyons
Hagop Kantarjian, Pierre Fenaux, Mikkael A. Sekeres, Pamela Becker, Adam Boruchov, David Bowen, Richard Larson, Petra Muus, Jamile Shammo, Michael Ehrman, Kuolung Hu, Janet Nichol

Blood
Phase 1/2 Study of AMG 531 in Thrombocytopenic Patients with Low Risk Myelodysplastic Syndrome (MDS): Update on Extended Treatment

Download full publication here.

Roger Lyons
Kantarjian H, Giles F, List A, Sekeres MA, Pierce S, Deuson R, Leveque J.

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

Nguyen PL, D'Amico AV, Lee AK, Suh WW
Cancer
Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature
de Crevoisier R, Melancon AD, Kuban DA, Lee AK, Cheung RM, Tucker SL, Kudchadker RJ, Newhauser WD, Zhang L, Mohan R, Dong L
International Journal of Radiation Oncology
Changes in the pelvic anatomy after an IMRT treatment fraction of prostate cancer
Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D
International Journal of Radiation Oncology
Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer
Zhang X, Dong L, Lee AK, Cox JD, Kuban DA, Zhu RX, Wang X, Li Y, Newhauser WD, Gillin M, Mohan R
International Journal of Radiation Oncology 
Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment

R. M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Tolerability and Hematologic Improvement Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

R.M. Lyons
T. Cosgriff, S. Modi, H. McIntyre, C. L. Beach, J. T. Backstrom

Journal of Clinical Oncology
Baseline Predictors of Response to Treatment with Darbepoeitin-alpha (DA) in Anemic Patients with Low-risk Myelodysplastic Syndrome (MDS)

Download full publication here.

R. M. Lyons
H. M. Kantarjian, F. J. Giles, P. Fenaux, P. S. Becker, A. M. Boruchov, D. T. Bowen, E. Hellström-Lindberg, R. A. Larson, P. Muus

Journal of Clinical Oncology
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Roger Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Roger Lyons, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Community and Supportive Oncology
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndrome

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Journal of Community and Supportive Oncology
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

Roger Lyons
David Kuter, James B. Bussel, James George, Louis Aledort, Alan Lichtin, Roger Lyons, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, and Janet Nichol

Journal of Community and Supportive Oncology
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura: 48-week Update

Download full publication here.

Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA
Journal of Urology
An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer
Zullo JR, Kudchadker R, Wu R, Lee A, Prado K
Medical Dosimetry
Implication of CT table sag on geometrical accuracy during virtual simulation
Sturgeon JD; Folsom AR
Neuroepidemiology
Trends in the hospitalization rate, hospital case fatality, and mortality rate of stroke by subtype in Minneapolis-St Paul.
Newhauser W, Fontenot J, Koch N, Dong L, Lee A, Zheng Y, Waters L, Mohan R
Physics in Medicine and Biology
Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate
Melancon AD, O'Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, Cheung RM, de Crevoisier R, Tucker SL, Newhauser WD, Mohan R, Dong L
Radiotherapy & Oncology
Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
Sturgeon JD; Folsom AR; Longstreth WT; Shahar E; Rosamond WO; Cushman M.
Stroke
Risk Factors for lntracerebral Hemorrhage in a Pooled Prospective Study.

R. Lyons
H.M. Kantarjian1, F. Giles, A.F. List, M. Sekeres4, S. Pierce1, R. Deuson, J. Leveque

Supportive Care Cancer
Thrombocytopenia in MDS: Incidence and Impact

Download full publication here.

R. M. Lyons
H.M. Kantarjian, F.J. Giles, P. Fenaux, P.S. Becker, A.M. Boruchov, D. Bowen, E. Hellstrom-Lindberg, R.A. Larson, R.M. Lyons, P. Muus

Supportive Care Cancer
Evaluating Safety and Efficacy of AMG 531 for the Treatment of Thrombocytopenic Patients with Myelodysplastic Syndrome (MDS): Preliminary Results of a Phase 1/2 Study

Download full publication here.

Lee AK
The American Journal of Hematology/Oncology
Commentary on "Cancer Specific Mortality After Radiation Therapy with Short-Course Hormonal Therapy or Radical Prostatectomy in Men with Localized, Intermediate-Risk to High-Risk Prostate Cancer"

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

The Cancer Journal
Renal Cell Carcinoma: Recent Advances.

Barker Jr., Jerry L., M.D. 
O’Daniel JC, Rosenthal DI, Garden AS, Ahamad A, Ang KK, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Patel CB, Schwartz DL, Wang H, Dong L.

American Journal of Clinical Oncology
The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy.

Shivnani, Anand M.D. 
 Small W Jr., Stryker SJ, et al.

American Journal of Surgery
Preoperative chemoradiation in rectal cancer: results of multimodality management and analysis of prognostic factors.

Hutson, Thomas E. DO, PharmD, FACP 

Baylor Health Care Center Proceedings
Targeted therapy for renal cell carcinoma: A new treatment paradigm

Estil A. Vance III, M.D. 
Drew J. Winson, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, George J. Alangaden, Roy F., Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, and Michael Boeckh.

Blood
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Hutson, Thomas E. DO, PharmD, FACP 
T Powles, CJ Sweeney, MD Galsky, N Hahn, and CN Sternberg.

British Journal of Urology International
Novel agents for urothelial cancer: review

Hutson, Thomas E. DO, PharmD, FACP 
K Chi, T Powles, CJ Sweeney, N Hahn, MD Galsky, WR Berry and D Kadman

Cancer
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.

Roger Lyons, MD
Hagop Kantarjian, MD, Francis Giles, MD, Alan List, MD, Mikkael A. Sekeres, MD, Sherry Pierce, BSN, Robert Deuson, PhD, Joseph Leveque, MD

Cancer
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes

Download full publication here.

Hutson, Thomas E. DO, PharmD, FACP 
George, T Mekhail, L Wood, J Finke, P Elson, R Dreicer, and RM Bukowski.

Cancer Chemotherapy and Pharmacology
Phase I trial of PEG-Intron and rIL-2 in patients with metastatic renal cell carcinoma

Pippen, John E., JR. MD, F.A.C.P. 
Blum J, Savin M, Edelamn G, et al.

Clinical Breast Cancer
Phase II study of weekly albumin bound paclitaxel for patients with breast cancer heavily pretreated with taxanes.

Blum, Joanne L. M.D., Ph.D. 
Freibel TM, Domcheck SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.

Clinical Breast Cancer
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 Mutation Carriers.

Blum, Joanne L. M.D., Ph.D. 
Savin M, Edelman G, Pippen J, Robert N, Geister B, Kirby R, Clawson A, O’Shaughessy J.

Clinical Breast Cancer
Phase 2 study of weekly nab-Paclitaxel for the treatment of patients with metastatic breast cancer heavily pretreated with taxanes.

Hutson, Thomas E. DO, PharmD, FACP

Current Oncology Report
A novel multitargeted tyrosine kinase inhibitor.

Hutson, Thomas E. DO, PharmD, FACP

Expert Opinion on Biological Therapy
Recent advances in the therapy of renal cancer.

Hutson, Thomas E. DO, PharmD, FACP 

Expert Review of Anticavity Therapy
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma – a phase III overview.

Blum, Joanne L. M.D., Ph. D. 
Kauff ND, Domcheck SM, Freibel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch HT, Eeles RA, Neuhasusen SL, Daly MB, Matloff E, Norton L, Offit K, Rebbeck TR.

Journal of Clinical Oncology
Recall injury from vinblastine: a case report.

Hoverman, J. Russell M.D. 
et. al.

Journal of Clinical Oncology
Assessment of medication safety in the outpatient setting.

Pippen, John E., JR. MD, F.A.C.P. 
Jones SE, Cantrell J, Vukelja S, et al.

Journal of Clinical Oncology
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: a report of a tamoxifen exemestane adjuvant multicenter trial substudy.

Patt, Debra M.D. 
Duan, Zhigang. Fang, Shenying. Hortobagyi, Gabriel N. and Giordano, Sharon H.

Journal of Clinical Oncology
Acute Myeloid Leukemia after Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk.

Mennel, Robert G. M.D., FACP 
Harris L, Fritsche H, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF. Bast RC Jr.

Journal of Clinical Oncology
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

Pippen, John E., JR. MD, F.A.C.P. 

Journal of Oncology Practice
Maintenance of certification: my perspective.

Shivnani, Anand M.D. 

Journal of the American Medical Association
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer (Letter ot Editor)

Hutson, Thomas E. DO, PharmD, FACP 
B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Negrier, C. Chevreau, E. Solska, A. Desai, F. Rolland, T. Demkow, M. Gore, S Freeman, B Schwartz, M. Shan, R. Simantov, R.M. Bukowski for the Sorafenib TARGETs Clinical Trial Group.

New England Journal of Medicine
Treatment Approaches in Renal cancer Global Evaluation Trial (TARGETs)

Hutson, Thomas E. DO, PharmD, FACP 
RJ Motzer, P Tomczak, MD Michaelson, RM Bukowski, O Rixie, S Oudard, S Negrier, C Szczylik, ST Kim, I Chen, CM Baum and RA Figlin

New England Journal of Medicine
Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma.

Shivnani, Anand M.D. 

New England Journal of Medicine
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer.

Hutson, Thomas E. DO, PharmD, FACP 
BJ Roth

Oncologist
Management of recurrent testicular germ cell tumors.

Hutson, Thomas E. DO, PharmD, FACP 
RA Figlin

Oncology
The evolving role of novel targeted agents in renal cell carcinoma.

Goldman, Stan M.D. 
Rakheja D, Wilson K, Lenarsky C, Weinthal J, Schultz R.

Pediatric and Developmental Pathology
Translocation associated primitive round cell sarcoma: report of a case and review of the literature.

Pippen, John E., JR. MD, F.A.C.P. 
Gong Y, Yan K, et al.

The Lancet
Determination of oestrogen-receptor status and erb b2 status of breast carcinoma: a gene expression profiling study.

Hutson, Thomas E. DO, PharmD, FACP 
E Segota, T Mekhail, T Olencki, R Dreicer, B Wacker, B Osterwalder, P Elson, M Zhou, and RM Bukowski

Urology Oncology
Phase II trial of capecitabine and rHU-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy and moderate toxicity.

McCollum, David M.D. 
Bingyan Wu, Jeffrey W. Clark, Matthew H. Kulke, Peter C. Enzinger, David P. Ryan, Craig Earle, Ann Michelini, Charles S. Fuchs, MD, MPH.

American Journal of Clinical Oncology
The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer.

Hutson, Thomas E. DO, PharmD, FACP 
TK Choueiri, T Mekhail, R Ganapathi, GE Kelly and RM Bukowski

Annals of Oncology
Phase I trial of phenoxodiol delivered by continuous intravenous infusion.
DeZee, Kent J and Shimeall, William T and Douglas, Kevin M and Shumway, Nathan M and O’Malley, Patrick G
Archives of Internal Medicine
Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis

John Sandbach, M.D.
John Cox, M.D.; Marcus Neubauer, M.D.; Andrew D. McCollum, M.D.; Thomas Cartwright, M.D.; Michael A. Monticelli, M.D.; Kristi A. Boehm, M.S.; Des Ilegbodu, DrPh; Lina Asmar, Ph.D.

ASCO Gastrointestinal Cancers Symposium
A Phase II study of gemcitabine plus zoledronic acid in Stage IV cancer of the pancreas.

Cooper, Barry, M.D. 
Gregory, T.F.

Baylor University Medical Center Proceedings
Case report of an acquired factor XIII inhibitor: diagnosis and management.

Cooper, Barry, M.D. 
Roberts, W.C.

Baylor University Medical Center Proceedings
MD: a conversation with the editor.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
The Clinical and Direct Medical Cost Burden of Splenectomy Among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP)

Download full publication here.

Roger M. Lyons
Louis M. Aledort, Gary Okano, Joseph Leveque

Blood
Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use

Download full publication here.

Roger M. Lyons
David Kuter, James Bussel, James George, Louis Aledort, Alan Lichtin, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, Janet Nichol

Blood
Long-term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenia Purpura: 48-week Update

Download full publication here.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Blood
The Incidence and Impact of Thrombocytopenia in Myelodysplastic Syndromes (MDS)

Download full publication here.

Roger M. Lyons
Thomas Cosgriff, Sanjiv Modi, Heidi McIntyre, C.L. Beach, Jay T. Backstrom

Blood
Hematologic Improvement, Transfusion Independence, and Safety Assessed Using Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

Roger M. Lyons
Janice Gabrilove, Ronald Paquette, Chaudhry Mushtaq, Mikkael A. Sekeres, Hung Lam, Lyndah Dreiling

Blood
The Efficacy and Safety of Darbopoetin Alfa For Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Results After 53-55 Weeks

Download full publication here.

John Sandbach
Frankie Ann Holmes, David Loesch, Sasha Vukelja, Joanne L Blum, Kristi J McIntyre, John E Pippen1, WJ Hyman, Don A Richards, Kristi Boehm, Lina Asmar, Joyce O’Shaughnessy.

Breast Cancer Research and Treatment
Are granulocyte colony-stimulating growth factors (CSF’s) needed to prevent febrile neutropenia (FN) for course #1 of adjuvant chemotherapy with “standard” doxorubicin-cyclophosphamide (ASC) Results from two consecutive US Oncology community adjuvant trials.

Balasubramanian, Lakshmi M.D. 
Bennett CL, Evens AM, Andritsos LA, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS.

British Journal of Haematology
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Hellerstedt, Beth M.D. 
Mackler NJ, Dunn RL, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC.

Cancer
Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone-Refractory Adenocarcinoma of the Prostate

Hutson, Thomas E. DO, PharmD, FACP 
RJ Halbert, RA Figlin, MB Atkins,  M Bernal, TE Hutson, RG Uzzo, RM Bukowki, KD Khan, RJ Motzer, CG Wood, and  R Dubois

Cancer
Treatment of Patients with Metastatic Renal Cell Carcinoma: A RAND appropriateness panel
Giordano SH, Lee A, Kuo YF, Freeman J, Goodwin JS
Cancer
Late gastrointestinal toxicity after radiation for prostate cancer
Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL
Cancer
Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA
Cancer
Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer

Roger M. Lyons, MD
Steven R. Deitcher, MD, Craig M. Kessler, MD, Geno Merli, MD, James R. Rigas, MD, Roger M. Lyons, MD, Jawed Fareed, PhD

Clinical and Applied Thrombosis/Hemostasis
Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Download full publication here.

Blum, Joanne L. M.D., Ph.D. 
O’Shaughnessy, JA.

Clinical Breast Cancer
Capecitabine/taxane combination therapy: evolving clinical utility in breast cancer.

Pippen, John E., JR. MD, F.A.C.P. 
Dodwell, D.

Clinical Breast Cancer
Time to response: comparison of fulvestrant and oral endocrine agents.

Hutson, Thomas E. DO, PharmD, FACP 
RM Bukowski

Clinical Genitourinary Cancer
A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma.

Hutson, Thomas E. DO, PharmD, FACP 
W Berry

Clinical Genitourinary Cancer
Systemic Chemotherapy for Urothelial Cancer.

Balasubramanian, Lakshmi M.D. 
Evens, AM.

Current Opinions in Oncology
Targeting angiogenesis for the treatment of sarcoma.

Barker Jr., Jerry L., M.D. 
Rosenthal DI, Asper JA, Garden AS, Chao KSC, Morrison WH, Weber RS, Ang KK.

Head Neck
Importance of patient examination to clinical quality assurance in head and neck radiation.
Lee AK, Frank SJ
Hematology/Oncology Clinics of North America
Update on radiation therapy in prostate cancer
Zhang Y, Zhang L, Zhu XR, Lee AK, Chambers M, Dong L
International Journal of Radiation Oncology
Reducing metal artifacts in cone-beam CT images by preprocessing projection data
O'Daniel JC, Dong L, Zhang L, de Crevoisier R, Wang H, Lee AK, Cheung R, Tucker SL, Kudchadker RJ, Bonnen MD, Cox JD, Mohan R, Kuban DA
International Journal of Radiation Oncology 
Dosimetric comparison of four target alignment methods for prostate cancer radiotherapy

Blum, Joanne L. M.D., Ph.D. 
Dees EC, Chacko A, Loane L, Ethirajan S, Hopkins J, McMahon R, Merten S,  Negron A, Neubauer M, Ilegbodu D, Boehm K, Asmar L, O’Shaughnessy JA.

Journal of Clinical Oncology
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.

Blum, Joanne L. M.D., Ph.D. 
Jones SE, Savin MA. Holmes FA, O’Shaughnessy JA, Vukelja S, McIntryre KJ, Pippen JE, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Mayer WG, and Asmar L,.

Journal of Clinical Oncology
Results of a Phase III trial doxoroubicin/cyclophosphamide (AC) compared to docetaxel/cyclophosphamide (TC) as adjuvant therapy for operable breast cancer.

Hoverman, J. Russell M.D. 
Hansen K, Richardson D, Shuey K.M., Dugger P.C.

Journal of Clinical Oncology
The Development of an Outpatient Chemotherapy Medication Safety Program.

Hutson, Thomas E. DO, PharmD, FACP 
Galsky, and WR Berry

Journal of Clinical Oncology
Problems with randomized discontinuation design.

Roger M. Lyons
Hagop M. Kantarjian, Francis Giles, Alan F. List, Sherry Price, Robert Deuson, Joseph Leveque

Journal of Clinical Oncology
Darbopoetin Alfa for Treating Anemia in Low-Risk Myelodysplastic Syndrome Patients: Interim Results After 27/28 Weeks

Download full publication here.

Roger M. Lyons
J. Gabrilove, R. Paquette, C. Mushtaq, M. Sekeres, H. Lam, L. Dreiling

Journal of Clinical Oncology
Darbepoetin Alfa for Treating Anemia in Patients with Low-Risk Myelodysplastic Syndromes: Exploratory Analysis of Baseline Predictors of Response

Download full publication here.

Roger M. Lyons
S. Anthony, T. Cosgriff, S. Modi

Journal of Clinical Oncology
Transfusion Independence Assessed During Three Alternative Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndromes

Download full publication here.

John Sandbach
Stephen E Jones, Michael A. Savin, Frankie Ann Holmes, Joyce A. O’Shaughnessy, Joanne L. Blum, Svetislava Vukelja, Kristi J. McIntyre, John E. Pippen, James H. Bordelon, Robert Kirby, William J. Hyman, Pankaj Khandelwal, Angel G. Negron, Donald A. Richards, Stephen P. Anthony, Robert G. Mennel, Kristi A. Boehm, Walter G. Meyer, Lina Asmar.

Journal of Clinical Oncology
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer. 

Roger M. Lyons, M.D.
James B. Bussel, M.D., David J. Kuter, M.D., D.Phil., James N. George, M.D., Robert McMillan, M.D., Louis M. Aledort, M.D., George T. Conklin, M.D., Alan E. Lichtin, M.D., Jorge Nieva, M.D., Jeffrey S. Wasser, M.D., Israel Wiznitzer, M.D., Reggie Kelly, B.S., Chien-Feng Chen, Ph.D., Janet L. Nichol, M.S.

New England Journal of Medicine
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP

Download full publication here.

Shivnani, Anand M.D. 
 Rimel BJ, Schink J, and Small W Jr..

Oncology
Cancer of the Cervix: Current Management and New Approaches.

McCollum, David M.D. 

Proc (Bayl Univ Med Cent)
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.
Lee AK
Seminars in Radiation Oncology
Radiation therapy combined with hormone therapy for prostate cancer

Esler, William Vance, M.D. 
Rohrer JE, Saeed Q, Saeed S, Periman P, Beggs D, Hancock P, Lim S.H.

Support Care Center
Risk of mistaken DNR orders.

Hoverman, J. Russell M.D. 
Syrigos KN, Nutting CM, Roussos C, eds.

Tumors of the Chest - Biology, Diagnosis and Management
Financial Aspects of Lung Cancer.
Chawla, Jane S.
UT Southwestern
Acute Intermittent Porphyria

Patt, Debra M.D. 
Giordano, Sharon H.

Women's Health
Paclitaxel in Breast Cancer.
Lee CT, Dong L, Ahamad AW, Choi H, Cheung R, Lee AK, Horne DF, Breaux AJ, Kuban DA
American Journal of Clinical Oncology
Comparison of treatment volumes and techniques in prostate cancer radiation therapy
Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL
Cancer
Symptomatic local recurrence of prostate carcinoma after radiation therapy
Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA 
International Journal of Radiation Oncology
Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy
Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D
International Journal of Radiation Oncology
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy
Wang H, Dong L, Lii MF, Lee AL, de Crevoisier R, Mohan R, Cox JD, Kuban DA, Cheung R
International Journal of Radiation Oncology
Implementation and validation of a three-dimensional deformable registration algorithm for targeted prostate cancer radiotherapy
Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D
International Journal of Radiation Oncology
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy
Lee AK, Levy LB, Cheung R, Kuban D
International Journal of Radiation Oncology
Prostate-specific antigen doubling time predicts clinical outcome and survival in prostate cancer patients treated with combined radiation and hormone therapy
Patt, D, Goodwin J, Kuo, Y, Freeman J, Zhang D, Buccholz T, Hortobagyi G, Giordano S.
Journal of Clinical Oncology
Cardiac morbidity of adjuvant radiotherapy in patients with early stage breast cancer
Lee AK, D'Amico AV
Journal of Clinical Oncology
Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy
Patt D, Shopland D, Anderson C, Burns D, Dunnington J, Gritz E.
Texas Medicine
Trends to protect workers from job related secondhand smoke in Texas
Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL
Urology
Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer?
Chawla, Jane S.
Washington University in St. Louis
Pharmacogenetics and Chemotherapy
Shumway, Nathan M and Weiss, Brendan M and Ketchum, Lloyd H and Reid, Thomas J
Blood
Hematology Consultation along with the 4 T’s Clinical Scoring System Improves the Evaluation and Management of Heparin Induced Thrombocytopenia.

John Sandbach, M.D.
David Loesch, M.D.; F. Anthony Greco, M.D., Joyce O’Shaughnessy, M.D.; Nicholas Robert, M.D.; Neil N. Senzer, M.D.; Howard A. Burris, M.D.; John D. Hainsworth, M.D.; Sasha Vukelja, M.D.; Frankie Holmes, M.D.; Scot Sedlacek, M.D.; Deborah Lindquist, M.D.; Kristi A. Boehm, M.D.; Feng Zhan, Ph.D.; Lina Asmar, Ph.D.

Breast Cancer Research and Treatment
A randomized, multicenter phase III trial comparing regimens of doxorubicin + cyclophosphamide followed by paclitaxel or doxorubicin + paclitaxel followed by weekly paclitaxel as adjuvant therapy for patients with high risk breast cancer.
Wilson, Ramey L and Eliasson, Arn H and Shumway, Nathan M and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Treating Air Hunger at End-of-Life
Shumway, Nathan M and Eliasson, Arn H and Wilson, Ramey L and Howard, Robin S and Shorr, Andrew F and Parker, Joseph M
CHEST Journal
Prospective Observation of Air Hunger in Severely Ill Patients
Court LE, Dong L, Taylor N, Ballo M, Kitamura K, Lee AK, O'Daniel J, White RA, Cheung R, Kuban D
International Journal of Radiation Oncology
Evaluation of a contour-alignment technique for CT-guided prostate radiotherapy: an intra- and interobserver study
Zagars GK, Ballo MT, Lee AK, Strom SS
Journal of Clinical Oncology
Mortality after cure of testicular seminoma
Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL
Journal of the National Medical Association
Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer
Citrin D, Lee AK, Scott T, Sproull M, Ménard C, Tofilon PJ, Camphausen K
Molecular Cancer Therapeutics
In vivo tumor imaging in mice with near-infrared labeled endostatin
Kamat AM, Rosser CJ, Levy LB, Chichakli R, Lee AK, Cheung MR, Pisters LL
Urology
Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure
Merill RM; Hilton SC; Wiggins CL; Sturgeon JD
BMC Cancer
Toward a better understanding of the comparatively high prostate cancer incidence rates in Utah.
Ballo MT, Lee AK
Current Opinion in Oncology
Current results of brachytherapy for soft tissue sarcoma
Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL
International Journal of Radiation Oncology
Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma
Lee HK, D'Souza WD, Yamal JM, Pollack A, Lee AK, Palmer MB, Kuban DA
International Journal of Radiation Oncology
Dosimetric consequences of using a surrogate urethra to estimate urethral dose after brachytherapy for prostate cancer
Selek U, Lee A, Levy L, Kuban DA
International Journal of Radiation Oncology
Utility of the percentage of positive prostate biopsies in predicting PSA outcome after radiotherapy for patients with clinically localized prostate cancer
Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL
Journal of Urology
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate
Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L
Rays
Uncertainties in physical and biological targeting with radiation therapy
Lee AK, Doytchinova T, Chen MH, Renshaw AA, Weinstein M, Richie JP, D'Amico AV
Urologic Oncology
Can the core length involved with prostate cancer identify clinically insignificant disease in low risk patients diagnosed on the basis of a single positive core?
Sturgeon JD; Folsom AR; Bray MS; Boerwinkle E; Ballantyne CM
Stroke
Apolipoprotein E Genotype and Incident lschemic Stroke. The Athersosclerosis Risk in Communities Study.
Shumway NM, Kelly WF, Moquin ME, Eliasson AH.
American Thoracic Society ATS
Treatment of air hunger at end of life
Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL
Journal of Urology
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer
Linson PW, Lee AK, Doytchinova T, Chen MH, Weinstein MH, Richie JP, D'Amico AV
Urology
Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
Lee AK, Schultz D, Renshaw AA, Richie JP, D'Amico AV
International Journal of Radiation Oncology
Optimizing patient selection for prostate monotherapy
Sukin SW, Chhikara, Zhu Z, Ayala G, Kadmon D, Miles BJ, Thompson TC, Aguilar-Cordova E
Molecular Therapy
In vivo surgical resection plus adjuvant gene therapy in the treatment of mammary and prostate cancer
Mutchnik SE, Sukin SW, Boone, TB
Contemporary Urology
Case studies in voiding dysfunction
Cho K, Hall W, Lee A, Gerbi B, Higgins P, Bohen M, Nussbaum E
Journal of Radiosurgery
Stereotactic radiosurgery for patients with single brain metastasis
Ingrams DR, Sukin SW, Ashton P, Valtonen HJ, Pankratov MM, Shapshay SM
Otolaryngology-Head and Neck Surgery
Does slow release of 5-fluorouracil and triamcinolone reduce subglottic stenosis?
Sielaff TD, Nyberg SL, Rollins MD, Hu MY, Amiot B, Lee A, Wu FJ, Hu WS, Cerra FB
Cell Biology and Toxicology
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver